Industry

In Phase 1 studies, cudetaxestat displayed low potential for drug-drug interactions when dosed with approved therapies for idiopathic pulmonary fibrosis (IPF) and other commonly used medications Cudetaxestat was well tolerated and showed no reports of treatment-related serious adverse events, including when co-administered with either pirfenidone or nintedanib, in healthy volunteers Cudetaxestat, an investigational non-competitive autotaxin … [Read more…]

Honoring blood collection professionals and their lifesaving impact on patient care LAKE ZURICH, Ill. & BETHESDA, Md.–(BUSINESS WIRE)–#BloodCollectorsWeek–Fresenius Kabi and AABB announced today the official start of the 17th annual Blood Collectors Week celebration, which runs September 4-10, 2022. Throughout the week, blood collectors are being honored for the lifesaving work they do each day … [Read more…]

The reported data suggest that patients with collateral ventilation may be able to undergo successful treatment with Zephyr Endobronchial Valves following closure of collateral air channels with the AeriSeal System REDWOOD CITY, Calif. & BARCELONA, Spain–(BUSINESS WIRE)–$LUNG #COPD–Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announces the … [Read more…]

$500m investment expands Pure Health’s footprint in the United States healthcare market. Ardent Health Services is the fourth largest private hospital operator in the United States with operations across six states. CHICAGO–(BUSINESS WIRE)–Alpha Dhabi Holding subsidiary, Pure Health, the largest integrated healthcare platform of the United Arab Emirates (UAE), today announced that it has entered … [Read more…]

ELMSFORD, N.Y.–(BUSINESS WIRE)–NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that, on August 30, 2022, the Company received notice from the Nasdaq Listing Qualifications Staff (the “Staff”) indicating that, based upon the Company’s continued non-compliance with Nasdaq’s minimum bid price … [Read more…]

JEFFERSON, N.J.–(BUSINESS WIRE)–#3DMammogram–A pioneering, state-of-the-art radiology center in New Jersey has officially announced its opening date to the public this month. Set to improve and redefine the medical diagnostic imaging experience for its patients, the new ImageCare Radiology location in Jefferson was launched on September 1, 2022 and will provide the most advanced medical diagnostic … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–The World Health Organization (WHO) recommended the use of condoms as a means of preventing potential monkeypox infections this week, following reports that viral DNA has been found in semen. The guidance comes several weeks after AIDS Healthcare Foundation first highlighted the importance of barrier protection for high-risk groups to reduce the risk … [Read more…]

If you or a loved one are in crisis, call 988. NASHVILLE, Tenn.–(BUSINESS WIRE)–#mentalhealth–Mental Health America of the MidSouth screening tools can help prevent a crisis. Suicide is the ninth leading cause of death in Tennessee, and major depression is the psychiatric diagnosis most associated with suicide. If you or a loved one are in … [Read more…]

-With this approval, approximately 300 children with two copies of the F508del mutation will have a medicine to treat the underlying cause of their disease for the first time- BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved expanded use of ORKAMBI® (lumacaftor/ivacaftor) to include children with cystic … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oak Hill Bio (“Oak Hill”), a clinical-stage neonatology and rare disease therapeutics company developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases, today announced that members of its senior leadership team will participate in one-on-one meetings with investors at the upcoming Citi 17th Annual BioPharma Conference taking place … [Read more…]